(The Center Square) – AstraZeneca has now joined Pfizer in agreeing to sell its drugs to state Medicaid programs at “most-favored-nation” pricing and deeply discounted rates on TrumpRx.gov

But what does that mean?

Last week, President Donald Trump and Health and Human Services officials announced the forthcoming creation of TrumpRx, a direct-to-consumer website where Americans will be able to buy some of their medications for less. They also unveiled the first-of-its-kind deal they’d reached with pharmaceutical giant Pfizer on drug pricing for Medicaid – a deal they’ve now secured with AstraZeneca, as well.

The drug manufacturers have also mentioned selling all of their new drugs at most-favored-nation pricing, though the implications of this are still unclear.

How it started

In May,

See Full Page